Suppr超能文献

低剂量硫柳汞注射诱导小鼠小脑和大脑中的金属硫蛋白。

Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection.

机构信息

Department of Life Sciences, Kinki University, Higashi-osaka, Osaka, Japan.

出版信息

Cell Biol Toxicol. 2010 Apr;26(2):143-52. doi: 10.1007/s10565-009-9124-z. Epub 2009 Apr 9.

Abstract

Thimerosal, an ethyl mercury compound, is used worldwide as a vaccine preservative. We previously observed that the mercury concentration in mouse brains did not increase with the clinical dose of thimerosal injection, but the concentration increased in the brain after the injection of thimerosal with lipopolysaccharide, even if a low dose of thimerosal was administered. Thimerosal may penetrate the brain, but is undetectable when a clinical dose of thimerosal is injected; therefore, the induction of metallothionein (MT) messenger RNA (mRNA) and protein was observed in the cerebellum and cerebrum of mice after thimerosal injection, as MT is an inducible protein. MT-1 mRNA was expressed at 6 and 9 h in both the cerebrum and cerebellum, but MT-1 mRNA expression in the cerebellum was three times higher than that in the cerebrum after the injection of 12 microg/kg thimerosal. MT-2 mRNA was not expressed until 24 h in both organs. MT-3 mRNA was expressed in the cerebellum from 6 to 15 h after the injection, but not in the cerebrum until 24 h. MT-1 and MT-3 mRNAs were expressed in the cerebellum in a dose-dependent manner. Furthermore, MT-1 protein was detected from 6 to 72 h in the cerebellum after 12 microg/kg of thimerosal was injected and peaked at 10 h. MT-2 was detected in the cerebellum only at 10 h. In the cerebrum, little MT-1 protein was detected at 10 and 24 h, and there were no peaks of MT-2 protein in the cerebrum. In conclusion, MT-1 and MT-3 mRNAs but not MT-2 mRNA are easily expressed in the cerebellum rather than in the cerebrum by the injection of low-dose thimerosal. It is thought that the cerebellum is a sensitive organ against thimerosal. As a result of the present findings, in combination with the brain pathology observed in patients diagnosed with autism, the present study helps to support the possible biological plausibility for how low-dose exposure to mercury from thimerosal-containing vaccines may be associated with autism.

摘要

硫柳汞,一种乙基汞化合物,被广泛用作疫苗防腐剂。我们之前观察到,小鼠大脑中的汞浓度并没有随着硫柳汞注射液的临床剂量增加而增加,但在注射脂多糖的同时注射硫柳汞后,即使给予低剂量的硫柳汞,其浓度也会在大脑中增加。硫柳汞可能穿透大脑,但在注射临床剂量的硫柳汞时无法检测到;因此,在注射硫柳汞后,我们观察到小脑和大脑中的金属硫蛋白(MT)信使 RNA(mRNA)和蛋白质被诱导,因为 MT 是一种可诱导的蛋白质。MT-1 mRNA 在大脑和小脑中均在 6 和 9 小时表达,但在小脑中的表达是大脑中的三倍,在注射 12 μg/kg 硫柳汞后。MT-2 mRNA 在两个器官中均在 24 小时后才表达。MT-3 mRNA 在小脑中从注射后 6 到 15 小时表达,但在大脑中直到 24 小时才表达。MT-1 和 MT-3 mRNA 在小脑中呈剂量依赖性表达。此外,在注射 12 μg/kg 硫柳汞后,MT-1 蛋白在小脑中从 6 小时到 72 小时被检测到,在 10 小时达到峰值。MT-2 仅在小脑中 10 小时被检测到。在大脑中,在 10 和 24 小时时很少检测到 MT-1 蛋白,并且在大脑中没有 MT-2 蛋白的峰值。总之,低剂量硫柳汞注射后,MT-1 和 MT-3 mRNA 而不是 MT-2 mRNA 很容易在小脑中而不是在大脑中表达。认为小脑是对硫柳汞敏感的器官。由于本研究的发现,结合对被诊断患有自闭症的患者的脑病理学研究,本研究有助于支持低剂量接触硫柳汞疫苗中的汞如何可能与自闭症相关的生物学可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验